CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The RNADIAGON project focuses on developing diagnostic biomarkers for early cancer detection using small non-coding RNAs. It aims to enhance the skills of researchers through training and collaboration with leading research centers in the United States.
Cancer occurs in more than 2 million individuals every year in Europe alone.
It is widely recognized that early diagnosis and monitoring of the disease - during therapy and post-treatment follow-up- is a key step for successful patient management: it helps to offer on-time curative intervention and selecting the most appropriate therapy, improves the quality of life, while contributing to reduce the economic and social burden for both patients and society.
There are screening programs available…
Masarykova univerzita
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Czechia, Brno
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Austria, Graz
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Romania, Cluj-Napoca
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Ferrara
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
